Zhejiang Hisun Pharmaceutical Co Ltd. Stock Analysis 600267.SS

Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products as well as veterinary medicines. The company is headquartered in Taizhou, Zhejiang and currently employs 8,751 full-time employees. The company went IPO on 2000-07-25. The firm mainly operates three businesses. The pharmaceutical manufacturing business includes pharmaceutical preparations business, pharmaceutical active pharmaceutical ingredients business and animal medicine business. The pharmaceutical commercial business includes pharmaceutical distribution business, imported pharmaceutical preparations and drug marketing outsourcing business. The emerging business is engaged in research and development in the field of synthetic biology and other businesses. The firm's main products include anti-tumor drugs, anti-infective drugs, cardiovascular drugs, antiparasitic drugs, veterinary drugs, endocrine drugs and other drugs. The firm conducts its business in the domestic and overseas markets.